Close MenuClose
Close Menu

Robin Farias-Eisner, MD, PhD

Professor

Robin Farias-Eisner

Contact

School of Medicine
Obstetrics and Gynecology

Robin Farias-Eisner, MD, PhD

Professor

Department

Obstetrics & Gynecology

Position

Professor

Articles

  • Int. J. Mol. Sci.
    Su F, Anantharamaiah GM, Mayakonda N, Palgunachari C, White R, Stessman H, Wu Y, Vadgama V, Pietras R, Nguyen D, Reddy ST, Farias-Eisner R. Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice. Int J Mol Sci. 2020 8: 1-15., p. 1-15 2020
  • Int. J. Mol. Sci.
    Su F, Spee C, Araujo E, Barron E, Wang M, Ghione C, Hinton DR, Nusinowitz S, Kannan R, Reddy ST, Farias-Eisner R. A Novel HDL-Mimetic Peptide HM-10/10 Protects RPE and Photoreceptors in Murine Models of Retinal Degeneration, Int J Mol Sci. 2019 Sep 27;20(19):4807
    19, p. 20 2019
  • BMC Med Genomics
    Nava M, Dutta P, Zemke NR, Farias-Eisner R, Vadgama JV, Wu Y. Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets BMC Med Genomics. 2019 8;12(1):32
    1, p. 12 2019
  • Sci Rep
    Nava M, Dutta P, Farias-Eisner R, Vadgama JV, Wu Y. Utilization of NGS technologies to investigate transcriptomic and epigenomic mechanisms in trastuzumab resistance. Sci Rep. 2019 Mar 26;9(1):5141. doi: 10.1038/s41598-019-41672-6.
    9(1), p. 5141 2019
  • Journal of Cancer Metastasis and Treatment
    Kaufman M, Cruz A, Thompson J, Reddy S, Bansal N, Cohen JG, Wu Y, Vadgama J, Farias-Eisner R. A review of the effects of healthcare disparities on the experience and survival of ovarian cancer patients of different racial and ethnic backgrounds. J Cancer Metastasis Treat. 2019;5. pii: 13. doi: 10.20517/2394-4722.2018.25. Epub 2019 Feb 27.
    2019;5, p. 13 2019
  • BMC Med Genomics
    Nava M, Dutta P, Zemke NR, Farias-Eisner R, Vadgama JV, Wu Y. Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets.doi: 10.1186/s12920-019-0477-8. 
    12(1), p. 32 2019
  • BMC Med Genomics
    Nava M, Dutta P, Zemke NR, Farias-Eisner R, Vadgama JV, Wu Y. Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets. BMC Med Genomics. 2019 Feb 8;12(1):32. doi: 10.1186/s12920-019-0477-8.
    1, p. 32 2019
  • Nature
    Devarajan A, Su F, Grijalva V, Yalamanchi M, Yalamanchi A, Gao F, Trost H, Nwokedi J, Farias-Eisner G, Farias-Eisner R, Fogelman AM, Reddy ST. Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer. Cell Death Dis. 2018 Mar 12;9(3):392. doi: 10.1038/s41419-018-0395-2. PMID: 29531225
    9(3), p. 392 2018
  • J Genet Couns
    Liang MI, Wong DH, Walsh CS, Farias-Eisner R, Cohen JG. Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers. J Genet Couns. 2017 Aug 7. doi: 10.1007/s10897-017-0135-2. [Epub ahead of print] PMID: 28785836 2017
  • Breast Cancer Research and Treatment
    Wu Y, Tran T, Dwabe S, Sarkissyan M, Kim J, Nava M, Clayton S, Pietras R, Farias-Eisner R, Vadgama JV. A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Breast Cancer Res Treat. 2017 Jun;163(3):449-460. doi: 10.1007/s10549-017-4211-y. Epub 2017 Mar 23.
    163(3), p. 449-460 2017
  • Oncogene
    Ramadoss S, Sen S, Ramachandran I, Roy S, Chaudhuri G, Farias-Eisner R. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance. Oncogene. 2017 Mar;36(11):1537-1545. doi: 10.1038/onc.2016.320. Epub 2016 Oct 3.
    36(11), p. 157-145 2016
  • Archives of Biochemistry and Biophysics
    Sen S, Kawahara B, Mahata SK, Tsai R, Yoon A, Hwang L, Hu-Moore K, Villanueva C, Vajihuddin A, Parameshwar P, You M, Bhaskar DL, Gomez O, Faull KF, Farias-Eisner R, Chaudhuri G. Cystathionine: A novel oncometabolite in human breast cancer. Arch Biochem Biophys. 2016 Aug 15;604:95-102. doi: 10.1016/j.abb.2016.06.010. Epub 2016 Jun 14.
    604, p. 95-102 2016
  • Archives of Biochemistry and Biophysics
    Sen S, Kawahara B, Mahata SK, Tsai R, Yoon A, Hwang L, Hu-Moore K, Villanueva C, Vajihuddin A, Parameshwar P, You M, Bhaskar DL, Gomez O, Faull KF, Farias-Eisner R, Chaudhuri G. Cystathionine: A novel oncometabolite in human breast cancer. Arch Biochem Biophys. 2016 Aug 15;604:95-102. doi: 10.1016/j.abb.2016.06.010. Epub 2016 Jun 14.
    604, p. 95-102 2016
  • Journal of Minimally Invasive Gynecology
    Parker W, Berek JS, Pritts E, Olive D, Kaunitz AM, Chalas E, Clarke-Pearson D, Goff B, Bristow R, Taylor HS, Farias-Eisner R, Fader AN, Maxwell GL, Goodwin SC, Love S, Gibbons WE, Foshag LJ, Leppert PC, Norsigian J, Nager CW, Johnson T, Guzick DS, As-Sanie S, Paulson RJ, Farquhar C, Bradley L, Scheib SA, Bilchik AJ, Rice LW, Dionne C, Jacoby A, Ascher-Walsh C, Kilpatrick SJ, Adamson GD, Siedhoff M, Israel R, Paraiso MF, Frumovitz MM, Lurain JR, Al-Hendy A, Benrubi GI, Raman SS, Kho RM, Anderson TL, Reynolds RK, DeLancey J. An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas. J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):303-8. doi: 10.1016/j.jmig.2015.12.012. Epub 2016 Jan 8.
    54(4), p. 995-1010 2016
  • In Press
    Coté JJ. Farias-Eisner R et al, Immunocompetent Mouse Models of Endometriosis: A Systematic Review, Meta-Analysis, and Call to Action, 2020 In Press -0001
  • In Press
    Coté JJ, Farias-Eisner R et al, COVID-19 and a novel initiative to improve safety by 3D printing personal protective equipment parts from computed tomography, 2020 3D Printing in Medicine In Press -0001
  • Int. J. Mol. Sci.
    Burnett Tarasiewicz M, Strother A, Farias-Eisner R et al, Early Endometrial Cancer Treatment: A Shifting Paradigm, Int J Mol Sci. 2020 in press -0001
  • Int. J. Mol. Sci.
    DeAngelo C, Burnett Tarasiewicz M, Strother A, Farias-Eisner R et al, Endometriosis and Cancer: A Malignant Molecular Profile, Int J Mol Sci. 2020 in press -0001
  • Journal of Cancer Research and Clinical Oncology
    Burnett Tarasiewicz M, Strother A, Farias-Eisner R et al, Pro-Inflammatory Predictors of Pre-Eclampia: A molecular Profie, J Cancer Res Therap Oncol 2020 in press -0001

General

  • Journal of Cancer Research and Clinical Oncology
    Burnett Tarasiewicz M, Strother A, Farias-Eisner R et al, Predictors of Oncofertility: A Molecular Profile, J Cancer Res Therap Oncol 2020 in press -0001

Presentations

  • COVID: Testing, Department of Obstetrics and Gynecology Grand Rounds, Creighton University, Internal Presentation 2020
  • Taking Discoveries from the Research Bench to Commercialization to the Patient Bedside: An Exciting Journey, Department of Obstetrics and Gynecology Grand Rounds, Creighton University, Internal Presentation 2020
  • Discoveries: From the Research Bench to the Patient Bedside – Physician Assistant Program, June, 2020 2020
  • Small Group Research Strategy 4: Medical Student; Creighton University School of Medicine; Creighton University; June, 2020. 2020
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; June, 2020. 2020
  • Discoveries: From the Research Bench to the Patient Bedside – Visiting Professor – Resident Graduation Day – Phoenix, Arizona June, 2020 2020
  • Small Group Research Strategy 3: Medical Student; Creighton University School of Medicine; Creighton University; June, 2020. 2020
  • Gynecologic Oncology – Physician Assistant Program, June, 2020 2020
  • Small Group Research Strategy 2: Medical Student; Creighton University School of Medicine; Creighton University; June, 2020. 2020
  • Introduction to Oncology – Physician Assistant Program, June, 2020 2020
  • Small Group Research Strategy 1: Medical Student; Creighton University School of Medicine; Creighton University; June, 2020. 2020
  • Small Group Research Strategy 4: Medical Student; Creighton University School of Medicine; Creighton University; May, 2020. 2020
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; May, 2020. 2020
  • Small Group Research Strategy 3: Medical Student; Creighton University School of Medicine; Creighton University; May, 2020. 2020
  • Small Group Research Strategy 2: Medical Student; Creighton University School of Medicine; Creighton University; May, 2020. 2020
  • Small Group Research Strategy 1: Medical Student; Creighton University School of Medicine; Creighton University; May, 2020. 2020
  • Small Group Research Strategy 4: Medical Student; Creighton University School of Medicine; Creighton University; April, 2020. 2020
  • Small Group Research Strategy 3: Medical Student; Creighton University School of Medicine; Creighton University; April, 2020. 2020
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; March, 2020. 2020
  • Small Group Research Strategy 2: Medical Student; Creighton University School of Medicine; Creighton University; April, 2020. 2020
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; April, 2020. 2020
  • Blood Supply to the Pelvis – Applied Anatomy and Clinical Implications; Medical Student Didactic lecture; Creighton University School of Medicine; Creighton University; April, 2020. 2020
  • Small Group Research Strategy 1: Medical Student; Creighton University School of Medicine; Creighton University; April, 2020. 2020
  • Small Group Research Strategy 4: Medical Student; Creighton University School of Medicine; Creighton University; March, 2020. 2020
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; March, 2020. 2020
  • Small Group Research Strategy 3: Medical Student; Creighton University School of Medicine; Creighton University; March, 2020. 2020
  • Blood Supply to the Pelvis – Applied Anatomy and Clinical Implications; Medical Student Didactic lecture; Creighton University School of Medicine; Creighton University; March, 2020 2020
  • Small Group Research Strategy 2: Medical Student; Creighton University School of Medicine; Creighton University; March, 2020. 2020
  • Small Group Research Strategy 1: Medical Student; Creighton University School of Medicine; Creighton University; March, 2020. 2020
  • An Impromptu Conversation, Department of Obstetrics and Gynecology Grand Rounds, Creighton University, Internal Presentation 2020
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; February, 2020. 2020
  • Comprehensive Review 2: Medical Student Didactic; Creighton University School of Medicine; Creighton University; February, 2020. 2020
  • Comprehensive Review 1: Medical Student Didactic; Creighton University School of Medicine; Creighton University; February, 2020 2020
  • Comprehensive Review 2: Medical Student Didactic; Creighton University School of Medicine; Creighton University; January, 2020. 2020
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; January, 2020. 2020
  • Endometrial Cancer – American Board of Obstetrics and Gynecology (ABOG) – Update; Grand Rounds; Department of Obstetrics and Gynecology; Creighton University School of Medicine; Creighton University; January, 2020. 2020
  • Comprehensive Review 1: Medical Student Didactic; Creighton University School of Medicine; Creighton University; January, 2020. 2020
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; December, 2019. 2019
  • Comprehensive Review 2: Medical Student Didactic; Creighton University School of Medicine; Creighton University; November, 2019. 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; November, 2019. 2019
  • Comprehensive Review 1: Medical Student Didactic; Creighton University School of Medicine; Creighton University; November, 2019. 2019
  • Susan G. Komen Great Plains: Celebration of Life event for My Sister’s Keeper, the African American Breast Cancer 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; October, 2019. 2019
  • "Rosie, The Orangutan" Grand Rounds; Department of Obstetrics and Gynecology; Creighton University School of Medicine; Creighton University September, 2019. 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; September, 2019. 2019
  • "Blood Supply to the Pelvis" Grand Rounds; Department of Obstetrics and Gynecology; Creighton University School of Medicine; Creighton University August, 2019. 2019
  • Comprehensive Review 2: Medical Student Didactic; Creighton University School of Medicine; Creighton University; August, 2019. 2019
  • Comprehensive Review 1: Medical Student Didactic; Creighton University School of Medicine; Creighton University; August, 2019. 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; August, 2019 2019
  • Ureteric Injuries in Obstetrics and Gynecology; Grand Rounds; Department of Obstetrics and Gynecology; Creighton University School of Medicine; Creighton University July, 2019. 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort – U54 NCI strategic planning; July, 2019. 2019
  • Discoveries: From the Research Bench to the Patient Bedside; Resident Research Day; Department of Obstetrics and Gynecology; Creighton University School of Medicine; Creighton University; June, 2019. 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight PACHE committee; UCLA, April, 2019. 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight IAC committee; UCLA, March, 2019. 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight IAC committee; UCLA, March, 2019. 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight PACHE committee; UCLA, January, 2019. 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight IAC committee; UCLA, January, 2019. 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight PACHE committee; UCLA, August, 2018. 2018
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight IAC committee; UCLA, July, 2018. 2018
  • “A Business-Driven Academic Healthcare System Enterprise Model of Academic Excellence”; Department of Obstetrics and Gynecology; UNLV Medical School, Las Vegas; March, 2018. 2018
  • “A Business-Driven Academic Healthcare System Enterprise Model of Academic Excellence”; American Hospital of Paris, Paris; March, 2018. 2018
  • “A Business-Driven Academic Healthcare System Enterprise Model of Academic Excellence”; Department of Obstetrics and Gynecology; University of Utah Medical School, Salt Lake City; November, 2017. 2017
  • “A Business-Driven Academic Healthcare System Enterprise Model of Academic Excellence”; Department of Obstetrics and Gynecology; Texas Tech Medical School, El Paso; September, 2017. 2017
  • “Investigator-Initiated Clinical Trials”. Carl and Roberta Deutsch Foundation seminar; Carl and Roberta Deutsch Foundation, Los Angeles, California, July, 2017. 2017
  • “A Business-Driven Academic Healthcare System Enterprise Model of Academic Excellence”; Department of Obstetrics and Gynecology; Rutgers Robert Wood Johnson Medical School, June, 2017. 2017
  • “Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries”; U54 NCI oversight committee; UCLA, April, 2017. 2017
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 IAC oversight committee; UCLA, February, 2017. 2017
  • Closing the Health Disparities’ Gap in Cancer Care; Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; Department of Obstetrics and Gynecology; Texas Tech Medical School, El Paso; September, 2016. 2016
  • Closing the Health Disparities’ Gap in Cancer Care; Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; Department of Obstetrics and Gynecology; Rutgers Robert Wood Johnson Medical School, August, 2016. 2016
  • “A Business-Driven Academic Healthcare System Enterprise Model of Academic Excellence”; Department of Obstetrics and Gynecology; University of Toledo, August, 2016. 2016
  • Closing the Health Disparities’ Gap in Cancer Care; Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; Department of Obstetrics and Gynecology; Rutgers Robert Wood Johnson Medical School, August, 2016. 2016
  • Closing the Health Disparities’ Gap in Cancer Care; Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; Department of Obstetrics and Gynecology; University of Toledo, August, 2016. 2016
  • “Investigator-Initiated Clinical Trials”. Carl and Roberta Deutsch Foundation seminar; Carl and Roberta Deutsch Foundation, Los Angeles, California, July, 2016. 2016
  • “Investigator-Initiated Clinical Trials”. Carl and Roberta Deutsch Foundation seminar; Carl and Roberta Deutsch Foundation, Los Angeles, California, July, 2016. 2016
  • “Investigator-Initiated Clinical Trials”. Carl and Roberta Deutsch Foundation seminar; Carl and Roberta Deutsch Foundation, Los Angeles, California, July, 2016. 2016
  • Closing the Health Disparities’ Gap in Cancer Care; Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; Department of Obstetrics and Gynecology; Texas Tech Medical School, El Paso; September, 2016. 2016
  • “Investigator-Initiated Clinical Trials”. Carl Deutsch Philanthropist discussion; Carl and Roberta Deutsch Foundation, Los Angeles, California, June 2016. 2016
  • “Investigator-Initiated Clinical Trials”. Carl Deutsch Philanthropist discussion; Carl and Roberta Deutsch Foundation, Los Angeles, California, June 2016. 2016
  • “Investigator-Initiated Clinical Trials”. Carl Deutsch Philanthropist discussion; Carl and Roberta Deutsch Foundation, Los Angeles, California, March 2016. 2016
  • “Investigator-Initiated Clinical Trials”. Carl Deutsch Philanthropist discussion; Carl and Roberta Deutsch Foundation, Los Angeles, California, March 2016. 2016
  • “Novel Diagnostic Platform”; Department of Obstetrics and Gynecology; Grand Rounds; David Geffen School of Medicine at UCLA, Los Angeles, California, January, 2016. 2016
  • “Novel Diagnostic Platform”; Department of Obstetrics and Gynecology; Grand Rounds; David Geffen School of Medicine at UCLA, Los Angeles, California, January, 2016. 2016

Awards

  • Charles F. and Mary C. Heider Endowed Chair in Cancer Research
    Creighton University